From time to time ASH will call on its members to reach out to Congress and state legislatures on issues of importance to hematologists and their patients. Below is a list of current issues of importance.
ASH Legislative Victory! Thank Congress for Passing Sickle Cell Disease Legislation
For the past several years, ASH has met with congressional offices and called on members of the ASH Grassroots Network to take action in support of the Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act (S. 2465). Because of your efforts and the work of ASH Grassroots Network advocates across the country, Congress is sending this important bill to President Trump to be signed into law.
Thank Your Member of Congress for Their Commitment to NIH Funding in FY 2019
Over the past several months, ASH has met with congressional offices and called on members of the ASH Grassroots Network to take action in support of increased funding for the National Institutes of Health (NIH). Because of your efforts and the work of medical research advocates across the country, Congress passed final fiscal year (FY) 2019 appropriations legislation in late September that included a $2 billion dollar increase to the NIH for a total funding level of $39.1 billion, a 5.4% funding boost over FY 2018 levels. President Trump signed the funding bill into law on September 28.
Urge Your Representative to Support the Cancer Drug Parity Act
Legislation has been introduced in the U.S. House of Representatives that would ensure that patients enrolled in certain federally regulated health plans have access and insurance coverage for all anti-cancer regimens. Your Representative needs to cosponsor these bills in order for them to be considered by the full Congress.
Contact Your Michigan House Member to Support HB 5367
Legislation has been introduced in the Michigan House of Representatives that would ensure that patients have access and insurance coverage for all anti-cancer regimens regardless of the form that they take.
Contact Your North Carolina State Senator in Support of H. 206
back to top
The Cancer Treatment Fairness Act (H.206) would require any health plan that provides coverage for cancer chemotherapy treatment to provide coverage for orally administered and self-injectable anticancer medications at a cost no less favorable than the cost of IV, port-administered, or injected anticancer medications. It is important you reach out to ask for your North Carolina state Senator's support.